| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Annals of Human Genetics |
| Vol/bind | 86 |
| Udgave nummer | 4 |
| Sider (fra-til) | 195-206 |
| Antal sider | 12 |
| ISSN | 0003-4800 |
| DOI | |
| Status | Udgivet - 2022 |
Bibliografisk note
Funding Information:InformationThis project was jointly supported by: The Danish Cancer Society (ref.: R218-A13150), NEYE Fonden, Odense Pancreas Center (OPAC), Odense University Hospital Research Fund, The Danish Cancer Research Fund (Dansk Kræftforskningsfond), Fonden til Lægevidenskabens Fremme (A.P. Møller Fonden), Fabrikant Einar Willumsens Mindelegat, the Rigshospitalet (RH)/Odense University Hospital (OUH) Research Fund (ref.: A3183), Aase og Ejnar Danielsens Fond (ref.: 18-10-0686).The authors want to issue a special thanks to the following hospital departments for their contribution with relevant benign FFPE tissue samples for the FPC patients included in this study: the Department of Pathology, Aalborg University Hospital, Aalborg, Denmark; the Department of Pathology, Aarhus University Hospital, Aarhus, Denmark; the Department of Pathology, Herlev Hospital, Herlev, Denmark; the Department of Pathology, Hospital of South West Jutland (Sydvestjysk Sygehus)—Esbjerg, Esbjerg, Denmark; the Department of Pathology, Hospital Sønderjylland (Sygehus Sønderjylland)—Sønderborg, Sønderborg, Denmark; the Department of Pathology, Hvidovre Hospital, Hvidovre, Denmark; the Department of Pathology, Næstved Hospital (Næstved Sygehus), Næstved, Denmark; the Department of Pathology, Odense University Hospital, Odense, Denmark; the Department of Pathology, Randers Regional Hospital (Regionshospitalet Randers), Randers, Denmark; the Department of Pathology, Rigshospitalet, Copenhagen, Denmark; the Department of Pathology, Vejle Hospital—Sygehus Lillebaelt, Vejle, Denmark; the Department of Pathology, Viborg Regional Hospital (Regionshospitalet Viborg), Viborg, Denmark; the Department of Pathology, Zealand University Hospital—Roskilde, Roskilde, Denmark.
Funding Information:
This project was jointly supported by: The Danish Cancer Society (ref.: R218‐A13150), NEYE Fonden, Odense Pancreas Center (OPAC), Odense University Hospital Research Fund, The Danish Cancer Research Fund (Dansk Kræftforskningsfond), Fonden til Lægevidenskabens Fremme (A.P. Møller Fonden), Fabrikant Einar Willumsens Mindelegat, the Rigshospitalet (RH)/Odense University Hospital (OUH) Research Fund (ref.: A3183), Aase og Ejnar Danielsens Fond (ref.: 18‐10‐0686).